Home Supplements How We Rate Blog
Nigella sativa

Black Seed

Research reviewed: Up until 03/2026

Black Seed (Nigella sativa) is a dietary supplement with 16 published peer-reviewed studies involving 773 participants, researched for Lipid Profile Improvement, Glycemic Control & Diabetes, Blood Pressure & Cardiovascular Risk and 6 more areas.

16
Studies
773
Participants
2013–2025
Research Span

Evidence at a Glance

Strength is scored by study design, sample size, study type, and outcomes

Overall: Moderate Evidence

Lipid Profile Improvement

Weak
1 study 1 of 1 positive 34 participants 0 human

Glycemic Control & Diabetes

Weak
1 study 0 of 1 positive 25 participants 0 human

Blood Pressure & Cardiovascular Risk

Moderate
2 studies 1 of 2 positive 152 participants 1 human

Inflammation & Oxidative Stress

Moderate
2 studies 1 of 2 positive 20 participants 1 human

Weight Loss & Obesity

Moderate
1 study 1 of 1 positive 40 participants

Blood Pressure & Cardiovascular

Moderate
2 studies 1 of 2 positive 70 participants 1 human

Blood Sugar

Weak
1 study 1 of 1 positive 8 participants 0 human

Clinical trials

Moderate
3 studies 0 of 3 positive 424 participants

Systematic reviews

Weak
3 studies 0 of 3 positive 0 participants 0 human

Research Visualised

Visual breakdown of the clinical data.

Study Quality Breakdown

What types of studies were conducted

9/16
Randomised
6/16
Double-Blind
6/16
Placebo-Controlled

Participants Per Study

Larger samples = more reliable results

Study 1 (2024)
34
Study 1 (2020)
25
Study 1 (2025)
82
Study 2 (2018)
70
Study 1 (2023)
20
Study 2 (2023)
0
Study 1 (2024)
40
Study 1 (2013)
70

Research Timeline

When the studies were published

1
2013
1
2016
1
2018
2
2020
3
2023
4
2024
4
2025

All Studies

Detailed breakdown of each trial. Click to expand.

Lipid Profile Improvement

1

To evaluate the effects of Nigella sativa supplementation on plasma lipid levels.

2024 34 participants 8-24 weeks 1.0-3.0 g/day (seed or oil)
Review/Other Positive

Study Type

Systematic review & meta-analysis

Purpose

To evaluate the effects of Nigella sativa supplementation on plasma lipid levels.

Dose

1.0-3.0 g/day (seed or oil)

Participants

34 RCTs, 2,278 participants

Duration

8-24 weeks

Results

Significant reductions in total cholesterol (TC) (SMD: -1.78; 95% CI: -2.20, -1.37, p<0.001), triglycerides (SMD: -1.27; 95% CI: -1.67, -0.83, p<0.001), and LDL-C. A modest heterogeneous increase in HDL-C was also observed. The strength of evidence supports Nigella sativa as an effective lipid-lowering supplement.

How They Measured It

Total cholesterol (TC), triglycerides (TG), LDL-C, HDL-C

Read full study

Glycemic Control & Diabetes

1

To evaluate the effects of Nigella sativa on fasting blood glucose and HbA1c in diabetic and pre-diabetic adults.

2020 25 participants 8-16 weeks 1.0-3.0 g/day
Review/Other Positive

Study Type

Systematic review & meta-analysis

Purpose

To evaluate the effects of Nigella sativa on fasting blood glucose and HbA1c in diabetic and pre-diabetic adults.

Dose

1.0-3.0 g/day

Participants

25 RCTs, 1,200+ participants with diabetes and prediabetes

Duration

8-16 weeks

Results

Significant reductions in fasting blood sugar and HbA1c across included trials. Effects were stronger in Type 2 diabetics than in general populations. An updated 2024 meta-analysis (30 RCTs) confirmed FBS reduction (SMD: -1.71; p<0.001) and HbA1c reduction (SMD: -2.16; p<0.001). No significant effect on HOMA-IR was found due to heterogeneity.

How They Measured It

Fasting blood sugar (FBS), HbA1c, HOMA-IR, insulin levels

Read full study

Blood Pressure & Cardiovascular Risk

1

To comprehensively assess the effect of Nigella sativa on cardiometabolic indicators including BMI, blood pressure, and lipids.

2025 82 participants 4-24 weeks 0.5-3.0 g/day
Review/Other Positive

Study Type

GRADE-assessed systematic review & dose-response meta-analysis

Purpose

To comprehensively assess the effect of Nigella sativa on cardiometabolic indicators including BMI, blood pressure, and lipids.

Dose

0.5-3.0 g/day

Participants

82 RCTs, 4,500+ participants

Duration

4-24 weeks

Results

Comprehensive analysis found significant reductions in BMI (-0.84 kg/m²), SBP (-3.2 mmHg), DBP (-2.1 mmHg), total cholesterol (-28.5 mg/dL), LDL (-21.3 mg/dL), and triglycerides (-17.8 mg/dL). The optimal dose identified was 3,000 mg/day for 12 weeks. This is the largest and most comprehensive meta-analysis of Nigella sativa to date.

How They Measured It

BMI, systolic and diastolic blood pressure, TC, LDL, triglycerides

Read full study
2

To evaluate the blood pressure lowering effect of Nigella sativa oil in hypertensive patients.

2018 70 participants 8 weeks 1.5 g/day (3 capsules of 500 mg)
Human Study RCT Double-Blind Placebo Positive

Study Type

Randomised, double-blind, placebo-controlled

Purpose

To evaluate the blood pressure lowering effect of Nigella sativa oil in hypertensive patients.

Dose

1.5 g/day (3 capsules of 500 mg)

Participants

70 hypertensive patients

Duration

8 weeks

Results

Significant SBP reduction (-7.9 mmHg, p<0.01) and DBP reduction (-4.3 mmHg, p<0.05) compared to placebo. The supplement was well-tolerated and no medication adjustments were required during the study.

How They Measured It

Systolic blood pressure (SBP), diastolic blood pressure (DBP)

Read full study

Inflammation & Oxidative Stress

1

To assess the effects of Nigella sativa on inflammatory and oxidative stress biomarkers.

2023 20 participants 8-16 weeks 1.0-3.0 g/day
Review/Other Positive

Study Type

Systematic review & meta-analysis

Purpose

To assess the effects of Nigella sativa on inflammatory and oxidative stress biomarkers.

Dose

1.0-3.0 g/day

Participants

20 RCTs, 1,086 participants

Duration

8-16 weeks

Results

Significant reductions in CRP (SMD: -2.28; 95% CI -3.20, -1.37, p<0.001) and TNF-α (SMD: -1.21; 95% CI -2.15, -0.26, p=0.013). Oxidative stress marker MDA was also significantly reduced. Results consistently showed that Nigella sativa decreases systemic inflammation and oxidative stress, supporting its broad anti-inflammatory profile.

How They Measured It

CRP, TNF-α, MDA (malondialdehyde), IL-1β, IL-6

Read full study
2

To examine effects of black seed supplementation on inflammatory markers (IL-1β, IL-6), leptin, and insulin parameters in overweight/obese women

2023 ? participants Crossover study design Black seed (Nigella sativa) supplementation
Human Study RCT Mixed

Study Type

Crossover randomized controlled trial

Purpose

To examine effects of black seed supplementation on inflammatory markers (IL-1β, IL-6), leptin, and insulin parameters in overweight/obese women

Dose

Black seed (Nigella sativa) supplementation

Participants

Overweight and obese women

Duration

Crossover study design

Results

Black seed supplementation reduced inflammatory markers and improved insulin sensitivity in overweight/obese women

How They Measured It

Serum IL-1β, IL-6, leptin, insulin, HOMA-IR

Read full study

Weight Loss & Obesity

1

To evaluate Nigella sativa effects on inflammatory biomarkers and metabolic parameters in overweight and obese women.

2024 40 participants 8 weeks per arm 2.0 g/day (seeds)
Human Study RCT Double-Blind Placebo Positive

Study Type

Randomised, double-blind, placebo-controlled, crossover

Purpose

To evaluate Nigella sativa effects on inflammatory biomarkers and metabolic parameters in overweight and obese women.

Dose

2.0 g/day (seeds)

Participants

40 overweight and obese women

Duration

8 weeks per arm

Results

Significant reductions in IL-1β, IL-6, and leptin levels. Insulin parameters improved. Modest weight loss of approximately 1.8 kg was observed. Results support Nigella sativa's combined anti-inflammatory and metabolic benefits in overweight women.

How They Measured It

IL-1β, IL-6, leptin, insulin parameters, body weight

Read full study

Blood Pressure & Cardiovascular

1

To evaluate blood pressure lowering effect of Nigella sativa seed oil in healthy volunteers

2013 70 participants Study period Nigella sativa seed oil
Human Study RCT Double-Blind Placebo Positive

Study Type

Randomised, double-blind, placebo-controlled trial

Purpose

To evaluate blood pressure lowering effect of Nigella sativa seed oil in healthy volunteers

Dose

Nigella sativa seed oil

Participants

70 healthy volunteers

Duration

Study period

Results

Systolic and diastolic blood pressure decreased significantly in the Nigella sativa oil treated group compared with baseline and placebo group.

How They Measured It

Systolic and diastolic blood pressure

Read full study
2

To assess effects of Nigella sativa supplementation on blood pressure

2016 ? participants Various study periods Nigella sativa (various forms and doses)
Review/Other RCT Mixed

Study Type

Meta-analysis of randomized controlled trials

Purpose

To assess effects of Nigella sativa supplementation on blood pressure

Dose

Nigella sativa (various forms and doses)

Participants

Meta-analysis of multiple RCTs

Duration

Various study periods

Results

Nigella sativa supplementation effective in reducing both systolic BP (WMD: -3.06 mmHg) and diastolic BP (WMD: -2.69 mmHg).

How They Measured It

Systolic and diastolic blood pressure

Read full study

Blood Sugar

1

To evaluate Nigella sativa supplementation effects on blood sugar and glycemic control

2020 8 participants Various study periods Nigella sativa (various doses)
Review/Other RCT Positive

Study Type

Systematic review of randomized controlled trials

Purpose

To evaluate Nigella sativa supplementation effects on blood sugar and glycemic control

Dose

Nigella sativa (various doses)

Participants

Meta-analysis of 8+ RCTs in diabetic and prediabetic patients

Duration

Various study periods

Results

Nigella sativa significantly improved fasting blood sugar (FBS), hemoglobin A1c (HbA1c), and postprandial blood glucose (PPBG) in multiple studies.

How They Measured It

Fasting blood sugar, HbA1c, postprandial glucose

Read full study

Clinical trials

1

To investigate the effects of Black Seed in a randomized, double-blind, placebo-controlled study to evaluate the benefits of a standardized nigella sativa oil containing 5% thymoquinone in reduc

2024 ? participants Duration not specified Black Seed (dose not specified)
Human Study RCT Double-Blind Placebo Mixed

Study Type

Randomized, double-blind, placebo-controlled

Purpose

To investigate the effects of Black Seed in a randomized, double-blind, placebo-controlled study to evaluate the benefits of a standardized nigella sativa oil containing 5% thymoquinone in reduc

Dose

Black Seed (dose not specified)

Participants

Participants not specified

Duration

Duration not specified

Results

Allergic rhinitis (AR) or seasonal allergy characterized by sneezing, nasal congestion, nasal itching, and nasal discharge, triggered by immune reactions to environmental allergens. Present day customers also monitor the personal improvements in the area of Evidence-Based natural medicines/supplements.

How They Measured It

See study for outcome measures

Read full study
2

To investigate the effects of Black Seed in nigella sativa as an antibiotic alternative to promote growth and enhance health of broilers challenged with eimeria maxima and clostridium perfringen

2023 384 participants Duration not specified Black Seed (dose not specified)
Human Study RCT Double-Blind Placebo Mixed

Study Type

Randomized, double-blind, placebo-controlled

Purpose

To investigate the effects of Black Seed in nigella sativa as an antibiotic alternative to promote growth and enhance health of broilers challenged with eimeria maxima and clostridium perfringen

Dose

Black Seed (dose not specified)

Participants

384 and 320 Cobb 500 male broiler chicks distributed in a randomized complete block experimen

Duration

Duration not specified

Results

, BCSO at concentrations of 2 and 5 mL/kg enhanced broiler live performance and alleviated NE and has potential as a natural, non-medication antimicrobial nutritional supplement for use as a feed additive in chickens.

How They Measured It

See study for outcome measures

Read full study
3

To investigate the effects of Black Seed in therapeutic potential of thymoquinone in conjunction with mechanical debridement for peri-implantitis: a prospective clinical evaluation.

2025 40 participants 3 months Black Seed (dose not specified)
Human Study RCT Double-Blind Placebo Positive

Study Type

Randomized, double-blind, placebo-controlled

Purpose

To investigate the effects of Black Seed in therapeutic potential of thymoquinone in conjunction with mechanical debridement for peri-implantitis: a prospective clinical evaluation.

Dose

Black Seed (dose not specified)

Participants

40 participants

Duration

3 months

Results

ntly better outcomes in PI (0.50 ± 0.20), GI (0.62 ± 0.11), PPD (3.02 ± 0.14 mm), and CAL (3.17 ± 0.31 mm) compared to Group 1 (p < 0.05). Thymoquinone gel as an adjunct to mechanical debridement significantly improves peri-implantitis management, offering a promising therapeutic option. Further studies with longer follow-up are needed to confirm its long-term effectiveness.

How They Measured It

See study for outcome measures

Read full study

Systematic reviews

1

To investigate the effects of Black Seed in effects of nigella sativa and its constituents on inflammatory markers in ovalbumin-induced asthma model: a preclinical systematic review and meta-ana

2025 ? participants Duration not specified Black Seed (dose not specified)
Review/Other Mixed

Study Type

Systematic review and meta-analysis

Purpose

To investigate the effects of Black Seed in effects of nigella sativa and its constituents on inflammatory markers in ovalbumin-induced asthma model: a preclinical systematic review and meta-ana

Dose

Black Seed (dose not specified)

Participants

Participants not specified

Duration

Duration not specified

Results

Research demonstrates that Nigella sativa (N. sativa) and its principal constituents, including thymoquinone, thymol, carvacrol, and α-hederin, possess anti-inflammatory, antioxidant, and immunomodulatory properties. This meta-analysis aims to evaluate the preclinical evidence of N. sativa in an animal model of ovalbumin-induced asthma.

How They Measured It

See study for outcome measures

Read full study
2

To investigate the effects of Black Seed in effects of nigella sativa and its constituents on total white blood cells count and airway responsiveness value in ovalbumin-induced asthma models: a

2025 ? participants Duration not specified Black Seed (dose not specified)
Review/Other Mixed

Study Type

Systematic review and meta-analysis

Purpose

To investigate the effects of Black Seed in effects of nigella sativa and its constituents on total white blood cells count and airway responsiveness value in ovalbumin-induced asthma models: a

Dose

Black Seed (dose not specified)

Participants

Participants not specified

Duration

Duration not specified

Results

Evidence indicates that Nigella sativa (NS) and its key compounds such as carvacrol, thymoquinone, thymol, and α-hederin exhibit properties that reduce inflammation, act as antioxidants, and modulate the immune system. This meta-analysis investigated the preclinical evidence of NS reported in animal models of ovalbumin (OVA)-induced asthma.

How They Measured It

See study for outcome measures

Read full study
3

To investigate the effects of Black Seed in immune stimulatory effect of nigella sativa in healthy animal models: a systematic review and meta-analysis.

2024 ? participants Duration not specified Black Seed (dose not specified)
Review/Other Mixed

Study Type

Systematic review and meta-analysis

Purpose

To investigate the effects of Black Seed in immune stimulatory effect of nigella sativa in healthy animal models: a systematic review and meta-analysis.

Dose

Black Seed (dose not specified)

Participants

Participants not specified

Duration

Duration not specified

Results

, black seeds enhance humoral immunity in healthy animals but do not affect cellular immunity.

How They Measured It

See study for outcome measures

Read full study

Frequently Asked Questions

Common questions about Black Seed research

What does the research say about Black Seed?

There are currently 16 peer-reviewed studies on Black Seed (Nigella sativa), involving 773 total participants. Research covers Lipid Profile Improvement, Glycemic Control & Diabetes, Blood Pressure & Cardiovascular Risk and 6 more areas. The overall evidence strength is rated as Moderate.

How strong is the evidence for Black Seed?

The evidence is currently rated as "Moderate Evidence". This rating is based on study design quality (randomisation, blinding, placebo controls), sample sizes, study types (7 human studies), and reported outcomes.

What health goals has Black Seed been studied for?

Black Seed has been researched for: Lipid Profile Improvement, Glycemic Control & Diabetes, Blood Pressure & Cardiovascular Risk, Inflammation & Oxidative Stress, Weight Loss & Obesity, Blood Pressure & Cardiovascular, Blood Sugar, Clinical trials, Systematic reviews. Each area has its own body of evidence which you can explore in the study breakdowns above.

Are the studies on Black Seed based on human trials?

Yes, 7 out of 16 studies are human trials. Human trials carry more weight in our evidence scoring system.